Open Access

Open Access at Emiko MedTech: Empowering Global Knowledge

Democratizing Discovery: Transforming Innovation into Universally Accessible Information.

At Emiko MedTech, we believe that the pursuit of a healthier future demands unrestricted access to scientific breakthroughs. Our commitment to Open Access (OA) ensures that the vital innovations published in our journals are immediately, freely, and universally available to researchers, clinicians, policymakers, and the public worldwide. We dismantle barriers to knowledge, accelerating the journey From Innovation to Information for the benefit of all.

What is Open Access Publishing?

Open Access means that published articles are available online, free of charge to the reader, immediately upon publication. There are no subscription fees, registration barriers, or pay-walls. Content can be freely downloaded, shared, and reused (with proper attribution) by anyone, anywhere.

The Power of Open Access: Benefits for Every collaborator

🡺 For Authors: Maximized Impact
Achieve higher visibility, greater readership, and increased citations. Your research directly impacts more minds, accelerating your influence in the MedTech community
🡺 For Researchers & Clinicians: Immediate Insight
Access critical, up-to-date research instantly, without barriers. Accelerate your own discoveries, inform clinical decisions, and foster new collaborations with ease.
🡺 For Institutions & Libraries: Expanded Reach
Empower your entire community with unlimited access to cutting-edge MedTech content, reducing subscription costs and enhancing the value of your institutional resources.
🡺 For Society: Accelerated Progress
Foster faster scientific progress, drive innovation in healthcare, and empower informed public discourse by making vital knowledge freely available to everyone who can benefit

We do not charge authors to publish with us, apart from under Open Access, when we require a fee to cover costs. Read more about our Open Access Option (Link for the information).

Authors publish their article as Open Access, which means the article will be freely available online to every reader anywhere in the world.

Does Emiko MedTech support Institutional Funding for APCs?

Please contact us if you are interested in discussing institutional payment models for article processing charges (APCs) for members of your organization.

Article Processing Charges (APCs): Fueling Accessibility & Quality

To cover the costs associated with publishing high-quality Open Access research – including rigorous peer review, professional editing, typesetting, production, article hosting, indexing, and global dissemination – Emiko MedTech applies an Article Processing Charge (APC) once a manuscript is accepted for publication. This one-time fee enables us to provide the comprehensive services that transform your innovation into reliable, globally accessible information.

Copyright licenses

What about copyright?

For all Open Access articles, Emiko MedTech authors retain full copyright to their work. By publishing with us, you agree to license your article under the Creative Commons Attribution (CC BY) license for global, open access. We require a warranty that your submitted article is original, has not been published elsewhere, and respects all intellectual property rights. Simultaneous submission to another journal is not permitted.

What is allowed concerning the published article?

Articles licensed under either CC BY or CC BY-NC-ND licenses may have any version posted on any website by anyone without embargo; however, please note:

  • Articles licensed under the CC BY license may be used for commercial purposes by anyone
  • Articles licensed under the CC BY-NC-ND license may not be used for commercial purposes by anyone and may not used to create derivative work by transforming or building upon the article by anyone other than you

When sharing or reposting any version of an Emiko MedTech article, a full citation to the journal as the original source of publication is required. Please include a link to the journal webpage and/or the article's Digital Object Identifier (DOI) as soon as they are available. This proper acknowledgment helps your work achieve maximum citation and impact.

When sharing or reposting any version of an Emiko MedTech article, a full citation to the journal as the original source of publication is required. Please include a link to the journal webpage and/or the article's Digital Object Identifier (DOI) as soon as they are available. This proper acknowledgment helps your work achieve maximum citation and impact.

Submit Manuscript